News

Donald Trump's recent weight loss, dropping from 244 to 214 pounds, has garnered attention. A key strategy involved ...
Eli Lilly raised its full-year profit forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug, ...
While the injections from Lilly and Novo have revolutionized the way obesity is treated, investors say pills are key to ...
Victoria Vigors is one of the many people using weight loss medication Mounjaro to shed the stubborn pounds. But after losing ...
In TODAY.com's Expert Tip of the Day, a cardiologist advises a simple change to boost heart health. It comes with many other ...
People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...
A new study shows that weight loss medication patients can experience hunger, eat well-balanced meals, and still make significant progress ...
Lisa Bernett, 44, was 20st 5lbs at her heaviest, with the funeral director stating she was even struggling to walk up the stairs at her home. She is now urging others to "take accountability" after ...
The investigational once-daily oral pill showed significant efficacy, and a safety and tolerability profile consistent with ...
The National Institute for Health and Care Excellence would then rule on whether it is cost-effective for NHS use.
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.